Merck & Co Inc/ US58933Y1055 /
8/12/2022 9:59:59 PM | Chg. +2.09 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
91.01USD | +2.35% | 322,133 Turnover: 29.14 mill. |
-Bid Size: - | -Ask Size: - | 230.58 bill.USD | 2.86% | 17.64 |
GlobeNewswire
1/11
Aligos Therapeutics Expands Collaboration with Merck to Develop Oligonucleotide Therapies for NASH
GlobeNewswire
1/10
NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal ...